Ocular Therapeutix Inc. - notizie pubblicate 203 - letture 2.578


Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

28.05.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Ocular Therapeutix™ Reports First Quarter 2024 Results - Form 8-K

Ocular therapeutix™ reports first quarter 2024 results recent leadership appointments put ocular on track to become a leader in retinal care site activation and patient enrollmen ...

07.05.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Initial Registration Statement for Employee Benefit Plan - Form S-8

As filed with the securities and exchange commission on may 7, 2024 registration no. 333-_____ united states securities and exchange commission washington, d.c. 20549 form s-8 regi ...

07.05.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Ocular Therapeutix™ Reports First Quarter 2024 Results - Form 8-K

Ocular therapeutix™ reports first quarter 2024 results recent leadership appointments put ocular on track to become a leader in retinal care site activation and patient enrollmen ...

07.05.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Initial Registration Statement for Employee Benefit Plan - Form S-8

As filed with the securities and exchange commission on may 7, 2024 registration no. 333-_____ united states securities and exchange commission washington, d.c. 20549 form s-8 regi ...

07.05.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Ocular Therapeutix™ Reports First Quarter 2024 Results

Recent leadership appointments put ocular on track to become a leader in retinal care site activation and patient enrollment for axpaxli™ sol-1 phase 3 wet amd trial progressing ...

07.05.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Additional Proxy Soliciting Materials - Form DEFA14A

united states securities and exchange commission washington, d.c. 20549 schedule 14a proxy statement pursuant to section 14(a) of the securities exchange act of 1934 filed by the ...

07.05.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bedford, mass., may 06, 2024 (globe newswire) -- ocular therapeutix, inc. (nasdaq:ocul) ("ocular"), a biopharmaceutical company committed to enhancing people's vision and ...

07.05.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences

Bedford, mass., may 06, 2024 (globe newswire) -- ocular therapeutix, inc. (nasdaq:ocul, "ocular", the "company"), a biopharmaceutical company committed to enhan ...

06.05.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024

2024 ois retina and arvo meetings are being held in seattle, washington bedford, mass., may 03, 2024 (globe newswire) -- ocular therapeutix, inc. (nasdaq:ocul, "ocular", ...

03.05.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024

First quarter 2024 financial results to be reported on tuesday, may 7, 2024 investor day to replace first quarter 2024 earnings conference call; quarterly calls to resume regular c ...

02.05.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Annual Report - Form ARS

The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer ocular therapeutix inc. published this ...

29.04.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Proxy Statement - Form DEF 14A

Table of contents united states securities and exchange commission washington, d.c. 20549 schedule 14a proxy statement pursuant to section 14(a) of the securities exchange act of 1 ...

29.04.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Preliminary Proxy Statement - Form PRE 14A

Table of contents united states securities and exchange commission washington, d.c. 20549 schedule 14a proxy statement pursuant to section 14(a) of the securities exchange act of 1 ...

19.04.2024
Ocular Therapeutix Inc.

OCULAR THERAPEUTIX INC.

Amendment No. 3 to 2019 Inducement Stock Incentive Plan - Form 8-K

Amendment no. 3 to 2019 inducement stock incentive plan ocular therapeutix, inc's 2019 inducement stock incentive plan (the "plan"), pursuant to section 11(d) thereof, is ...

18.04.2024
Condividi